Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWBesifloxacin is an ophthalmologic fluoroquinolone antibiotic that is active against Gram-negative and Gram-positive aerobic and anaerobic bacterial strains (MICs = 0.006-1.56 μg/ml).1 It inhibits LPS-stimulated production of the inflammatory cytokines IL-1β, IL-8, IL-6, and IL-1α in human THP-1 monocytes.2 Besifloxacin, when 2 drops of a 0.6% solution are applied per eye, yields a concentration of 2 μg/g which is greater than the MIC90s of ophthalmologic isolates of H. influenzae, S. pneumoniae, S. aureus, and Corynebacterium and reduces the number of bacteria found in the aqueous, but not vitreous, humor in a rabbit model of bacterial endophthalmitis.1,3
WARNING This product is not for human or veterinary use.
1. Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-
2. Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-
3. Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-